Litcius/Paper detail

Minimal residual disease in multiple myeloma: defining the role of next generation sequencing and flow cytometry in routine diagnostic use

Kylee Maclachlan, Neil Came, Benjamin Diamond, Mikhail Roshal, Caleb Ho, Katie Thoren, Marius E. Mayerhoefer, Ola Landgren, Simon J. Harrison

2021Pathology21 citationsDOI

Topics & Concepts

Multiple myelomaMinimal residual diseaseFlow cytometryDNA sequencingMedicineComputational biologyDiseasePathologyImmunologyBiologyGeneticsGeneBone marrowMultiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsAmyloidosis: Diagnosis, Treatment, Outcomes
Minimal residual disease in multiple myeloma: defining the role of next generation sequencing and flow cytometry in routine diagnostic use | Litcius